tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CANbridge Pharmaceuticals Unveils New Board Structure

CANbridge Pharmaceuticals Unveils New Board Structure

CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

CANbridge Pharmaceuticals Inc. announces the composition of its Board of Directors, including the Chairman and CEO, Dr. James Qun Xue, along with a list of Non-executive and Independent Non-executive Directors. The company also outlines the structure of its three Board committees, specifying the chairpersons and members of each.

For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1